Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Blagosklonny, MV' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 72 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Liu, YQ; Kyle, E; Patel, S; Housseau, F; Hakim, F; Lieberman, R; Pins, M; Blagosklonny, MV; Bergan, RC
      Prostate cancer chemoprevention agents exhibit selective activity against early stage prostate cancer cells

      PROSTATE CANCER AND PROSTATIC DISEASES
    2. Kang, MH; Figg, WD; Ando, Y; Blagosklonny, MV; Liewehr, D; Fojo, T; Bates, SE
      The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6 alpha-hydroxypaclitaxel, a major metabolite of paclitaxel

      CLINICAL CANCER RESEARCH
    3. Blagosklonny, MV
      Hypoxia-inducible factor: Achilles' heel of antiangiogenic cancer therapy (Review)

      INTERNATIONAL JOURNAL OF ONCOLOGY
    4. Blagosklonny, MV; Dixon, SC; Robey, R; Figg, WD
      Resistance to growth inhibitory and apoptotic effects of phorbol ester andUCN-01 in aggressive cancer cell lines

      INTERNATIONAL JOURNAL OF ONCOLOGY
    5. Nicoletti, MI; Myers, TG; Fojo, T; Blagosklonny, MV
      Wild-type p53 marginally induces endogenous MDR-1 mRNA without causing a measurable drug resistance in human cancer cells

      INTERNATIONAL JOURNAL OF ONCOLOGY
    6. Blagosklonny, MV
      Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors

      ONCOGENE
    7. Giannakakou, P; Robey, R; Fojo, T; Blagosklonny, MV
      Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity

      ONCOGENE
    8. Blagosklonny, MV
      Unwinding the loop of Bcl-2 phosphorylation

      LEUKEMIA
    9. Blagosklonny, MV
      Treatment with inhibitors of caspases, that are substrates of drug transporters, selectively permits chemotherapy-induced apoptosis in multidrug-resistant cells but protects normal cells

      LEUKEMIA
    10. Blagosklonny, MV; Fojo, T; Bhalla, KN; Kim, JS; Trepel, JB; Figg, WD; Rivera, Y; Neckers, LM
      The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressingleukemia cells to cytotoxic chemotherapy

      LEUKEMIA
    11. Blagosklonny, MV
      Paradox of Bcl-2 (and p53): why may apoptosis-regulating proteins be irrelevant to cell death?

      BIOESSAYS
    12. Blagosklonny, MV; Giannakakou, P; Romanova, LY; Ryan, KM; Vousden, KH; Fojo, T
      Inhibition of HIF-1-and wild-type p53-stimulated transcription by codon Arg175 p53 mutants with selective loss of functions

      CARCINOGENESIS
    13. Blagosklonny, MV
      How carcinogens (or telomere dysfunction) induce genetic instability: associated-selection model

      FEBS LETTERS
    14. Blagosklonny, MV; Pardee, AB
      Exploiting cancer cell cycling for selective protection of normal cells

      CANCER RESEARCH
    15. Blagosklonny, MV
      Re: Role of the heat shock response and molecular chaperones in oncogenesis and cell death

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    16. Giannakakou, P; Sackett, DL; Ward, Y; Webster, KR; Blagosklonny, MV; Fojo, T
      p53 is associated with cellular microtubules and is transported to the nucleus by dynein

      NATURE CELL BIOLOGY
    17. Kim, JS; Pirnia, F; Choi, YH; Nguyen, P; Knepper, B; Tsokos, M; Schulte, TW; Birrer, MJ; Blagosklonny, MV; Schaefer, O; Mushinski, JF; Trepel, JB
      Lovastatin induces apoptosis in a primitive neuroectodermal tumor cell line in association with RB down-regulation and loss of the G-1 checkpoint

      ONCOGENE
    18. Giannakakou, P; Poy, G; Zhan, ZR; Knutsen, T; Blagosklonny, MV; Fojo, T
      Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer

      ONCOGENE
    19. Blagosklonny, MV
      p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect

      FASEB JOURNAL
    20. Blagosklonny, MV
      Spotlight on apoptosis

      LEUKEMIA
    21. Blagosklonny, MV
      Cell death beyond apoptosis

      LEUKEMIA
    22. An, WG; Hwang, SG; Trepel, JB; Blagosklonny, MV
      Protease inhibitor-induced apoptosis: accumulation of wt p53, p21(WAF1/CIP1) and induction of apoptosis are independent markers of proteasome inhibition

      LEUKEMIA
    23. Blagosklonny, MV
      The dilemma of apoptosis in myelodysplasia and leukemia: a new promise of therapeutic intervention?

      LEUKEMIA
    24. Blagosklonny, MV; Dixon, SC; Figg, WD
      Efficacy of microtubule-active drugs followed by ketoconazole in human metastatic prostate cancer cell lines

      JOURNAL OF UROLOGY
    25. Blagosklonny, MV; Robey, R; Bates, S; Fojo, T
      Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs

      JOURNAL OF CLINICAL INVESTIGATION
    26. Salnikow, K; Costa, M; Figg, WD; Blagosklonny, MV
      Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer

      CANCER RESEARCH
    27. Salnikow, K; Su, WC; Blagosklonny, MV; Costa, M
      Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism

      CANCER RESEARCH
    28. Blagosklonny, MV; Bishop, PC; Robey, R; Fojo, T; Bates, SE
      Loss of cell cycle control allows selective microtubule-active drug-induced Bcl-2 phosphorylation and cytotoxicity in autonomous cancer cells

      CANCER RESEARCH
    29. Salnikow, K; Blagosklonny, MV; Ryan, H; Johnson, R; Costa, M
      Carcinogenic nickel induces genes involved with hypoxic stress

      CANCER RESEARCH
    30. Sandor, V; Senderowicz, A; Mertins, S; Sackett, D; Sausville, E; Blagosklonny, MV; Bates, SE
      P21-dependent G(1) arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228

      BRITISH JOURNAL OF CANCER
    31. Bergan, RC; Reed, E; Myers, CE; Headlee, D; Brawley, O; Cho, HK; Figg, WD; Tompkins, A; Linehan, WM; Kohler, D; Steinberg, SM; Blagosklonny, MV
      A phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer

      CLINICAL CANCER RESEARCH
    32. Blagosklonny, MV; An, WG; Melillo, G; Nguyen, P; Trepel, JB; Neckers, LM
      Regulation of BRCA1 by protein degradation

      ONCOGENE
    33. Blagosklonny, MV; Chuman, Y; Bergan, RC; Fojo, T
      Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells

      LEUKEMIA
    34. Blagosklonny, MV
      Drug-resistance enables selective killing of resistant leukemia cells: exploiting of drug resistance instead of reversal

      LEUKEMIA
    35. Blagosklonny, MV
      A node between proliferation, apoptosis, and growth arrest

      BIOESSAYS
    36. Kruger, EA; Blagosklonny, MV; Dixon, SC; Figg, WD
      UCN-01, a protein kinase C inhibitor, inhibits endothelial cell proliferation and angiogenic hypoxic response

      INVASION & METASTASIS
    37. Salnikow, K; An, WG; Melillo, G; Blagosklonny, MV; Costa, M
      Nickel-induced transformation shifts the balance between HIF-1 and p53 transcription factors

      CARCINOGENESIS
    38. Romanova, LY; Alexandrov, IA; Blagosklonny, MV; Nordan, RP; Garfield, S; Acs, P; Nguyen, P; Trepel, J; Blumberg, PM; Mushinski, JF
      Regulation of actin cytoskeleton in lymphocytes: PKC-delta disrupts IL-3-induced membrane ruffles downstream of Rac1

      JOURNAL OF CELLULAR PHYSIOLOGY
    39. Blagosklonny, MV; Fojo, T
      Molecular effects of paclitaxel: Myths and reality (a critical review)

      INTERNATIONAL JOURNAL OF CANCER
    40. ROHLFF C; BLAGOSKLONNY MV; KYLE E; KESARI A; KIM IY; ZELNER DJ; HAKIM F; TREPEL J; BERGAN RC
      PROSTATE-CANCER CELL-GROWTH INHIBITION BY TAMOXIFEN IS ASSOCIATED WITH INHIBITION OF PROTEIN-KINASE-C AND INDUCTION OF P21(WAF1 CIP1)/

      The Prostate
    41. AN WG; KANEKAL M; SIMON MC; MALTEPE E; BLAGOSKLONNY MV; NECKERS LM
      STABILIZATION OF WILD-TYPE P53 BY HYPOXIA-INDUCIBLE FACTOR 1-ALPHA

      Nature
    42. BLAGOSKLONNY MV; GIANNAKAKOU P; WOJTOWICZ M; ROMANOVA LY; AIN KB; BATES SE; FOJO T
      EFFECTS OF P53-EXPRESSING ADENOVIRUS ON THE CHEMOSENSITIVITY AND DIFFERENTIATION OF ANAPLASTIC THYROID-CANCER CELLS

      The Journal of clinical endocrinology and metabolism
    43. BLAGOSKLONNY MV; AN WG; ROMANOVA LY; TREPEL J; FOJO T; NECKERS L
      P53 INHIBITS HYPOXIA-INDUCIBLE FACTOR-STIMULATED TRANSCRIPTION

      The Journal of biological chemistry
    44. BLAGOSKLONNY MV
      THE MITOGEN-ACTIVATED PROTEIN-KINASE PATHWAY MEDIATES GROWTH ARREST OR E1A-DEPENDENT APOPTOSIS IN SKBR3 HUMAN BREAST-CANCER CELLS

      International journal of cancer
    45. BLAGOSKLONNY MV; ELDEIRY WS
      ACUTE OVEREXPRESSION OF WT P53 FACILITATES ANTICANCER DRUG-INDUCED DEATH OF CANCER AND NORMAL-CELLS

      International journal of cancer
    46. AN WG; CHUMAN Y; FOJO T; BLAGOSKLONNY MV
      INHIBITORS OF TRANSCRIPTION, PROTEASOME INHIBITORS, AND DNA-DAMAGING DRUGS DIFFERENTIALLY AFFECT FEEDBACK OF P53 DEGRADATION

      Experimental cell research
    47. PORUCHYNSKY MS; WANG EE; RUDIN CM; BLAGOSKLONNY MV; FOJO T
      BCL-X(L) IS PHOSPHORYLATED IN MALIGNANT-CELLS FOLLOWING MICROTUBULE DISRUPTION

      Cancer research
    48. BLAGOSKLONNY MV; IGLESIAS A; ZHAN ZR; FOJO T
      LIKE P53, THE PROLIFERATION-ASSOCIATED PROTEIN P120 ACCUMULATES IN HUMAN CANCER-CELLS FOLLOWING EXPOSURE TO ANTICANCER DRUGS

      Biochemical and biophysical research communications
    49. ROMANOVA LY; ALEXANDROV IA; NORDAN RP; BLAGOSKLONNY MV; MUSHINSKI JF
      CROSS-TALK BETWEEN PROTEIN-KINASE-C-ALPHA (PKC-ALPHA) AND PKC-DELTA (PKC-DELTA) - PKC-ALPHA ELEVATES THE PKC-DELTA PROTEIN LEVEL, ALTERING ITS MESSENGER-RNA TRANSCRIPTION AND DEGRADATION

      Biochemistry
    50. BLAGOSKLONNY MV; WU GS; SOMASUNDARAM K; ELDEIRY WS
      WILD-TYPE P53 IS NOT SUFFICIENT FOR SERUM STARVATION-INDUCED APOPTOSIS IN CANCER-CELLS BUT ACCELERATES APOPTOSIS IN SENSITIVE CELLS

      International journal of oncology
    51. BLAGOSKLONNY MV
      LOSS OF FUNCTION AND P53 PROTEIN STABILIZATION

      Oncogene
    52. WHITESELL L; SUTPHIN P; AN WG; SCHULTE T; BLAGOSKLONNY MV; NECKERS L
      GELDANAMYCIN-STIMULATED DESTABILIZATION OF MUTATED P53 IS MEDIATED BYTHE PROTEASOME IN-VIVO

      Oncogene
    53. AN WG; SCHNUR RC; NECKERS L; BLAGOSKLONNY MV
      DEPLETION OF P185(ERBB2), RAF-1 AND MUTANT P53 PROTEINS BY GELDANAMYCIN DERIVATIVES CORRELATES WITH ANTIPROLIFERATIVE ACTIVITY

      Cancer chemotherapy and pharmacology
    54. BLAGOSKLONNY MV; PRABHU NS; ELDEIRY WS
      DEFECTS IN P21(WAF1 CIP1), RB, AND C-MYC SIGNALING IN PHORBOL ESTER-RESISTANCE CANCER-CELLS/

      Cancer research
    55. BLAGOSKLONNY MV; GIANNAKAKOU P; ELDEIRY WS; KINGSTON DGI; HIGGS PI; NECKERS L; FOJO T
      RAF-1 BCL-2 PHOSPHORYLATION - A STEP FROM MICROTUBULE DAMAGE TO CELL-DEATH/

      Cancer research
    56. PRABHU NS; BLAGOSKLONNY MV; ZENG YX; WU GS; WALDMAN T; ELDEIRY WS
      SUPPRESSION OF CANCER CELL-GROWTH BY ADENOVIRUS EXPRESSING P21(WAF1 CIP1) DEFICIENT IN PCNA INTERACTION/

      Clinical cancer research
    57. SCHULTE TW; BLAGOSKLONNY MV; ROMANOVA L; MUSHINSKI JF; MONIA BP; JOHNSTON JF; NGUYEN P; TREPEL J; NECKERS LM
      DESTABILIZATION OF RAF-1 BY GELDANAMYCIN LEADS TO DISRUPTION OF THE RAF-1-MEK-MITOGEN-ACTIVATED PROTEIN-KINASE SIGNALING PATHWAY

      Molecular and cellular biology
    58. BLAGOSKLONNY MV; ALVAREZ M; FOJO A; NECKERS LM
      BCL-2 PROTEIN DOWN-REGULATION IS NOT REQUIRED FOR DIFFERENTIATION OF MULTIDRUG-RESISTANT HL-60 LEUKEMIA-CELLS

      Leukemia research
    59. BLAGOSKLONNY MV; TORETSKY J; BOHEN S; NECKERS L
      MUTANT CONFORMATION OF P53 TRANSLATED IN-VITRO OR IN-VIVO REQUIRES FUNCTIONAL HSP90

      Proceedings of the National Academy of Sciences of the United Statesof America
    60. BLAGOSKLONNY MV; ELDEIRY WS
      IN-VITRO EVALUATION OF A P53-EXPRESSING ADENOVIRUS AS AN ANTICANCER DRUG

      International journal of cancer
    61. BLAGOSKLONNY MV; SCHULTE T; NGUYEN P; TREPEL J; NECKERS LM
      TAXOL-INDUCED APOPTOSIS AND PHOSPHORYLATION OF BCL-2 PROTEIN INVOLVESC-RAF-1 AND REPRESENTS A NOVEL C-RAF-1 SIGNAL-TRANSDUCTION PATHWAY

      Cancer research
    62. BLAGOSKLONNY MV; WU GS; OMURA S; ELDEIRY WS
      PROTEASOME-DEPENDENT REGULATION OF P21(WAF1 CIP1) EXPRESSION/

      Biochemical and biophysical research communications
    63. BLAGOSKLONNY MV; NECKERS LM
      THE ROLE OF BCL-2 PROTEIN AND AUTOCRINE GROWTH-FACTORS IN A HUMAN FOLLICULAR LYMPHOMA-DERIVED B-CELL LINE

      European cytokine network
    64. BLAGOSKLONNY MV; TORETSKY J; NECKERS L
      GELDANAMYCIN SELECTIVELY DESTABILIZES AND CONFORMATIONALLY ALTERS MUTATED P53

      Oncogene
    65. MACHULAITENE ER; BLAGOSKLONNY MV; LASUNSKAYA EB
      THE INFLUENCE OF PHORBOL DIESTHER ON PROL IFERATION AND DIFFERENTIATION OF PRIMARY BLAST CELLS FROM LEUKEMIA PATIENTS AND BLASTS SECRETION OF BIOLOGICALLY-ACTIVE AGENTS

      Gematologia i transfuziologia
    66. SCHULTE TW; BLAGOSKLONNY MV; INGUI C; NECKERS L
      DISRUPTION OF THE RAF-1-HSP90 MOLECULAR-COMPLEX RESULTS IN DESTABILIZATION OF RAF-1 AND LOSS OF RAF-1-RAS ASSOCIATION

      The Journal of biological chemistry
    67. BLAGOSKLONNY MV; SCHULTE TW; NGUYEN P; MIMNAUGH EG; TREPEL J; NECKERS L
      TAXOL INDUCTION OF P21(WAF1) AND P53 REQUIRES C-RAF-1

      Cancer research
    68. BLAGOSKLONNY MV; NECKERS LM
      OLIGONUCLEOTIDES PROTECT CELLS FROM THE CYTOTOXICITY OF SEVERAL ANTICANCER CHEMOTHERAPEUTIC DRUGS

      Anti-cancer drugs
    69. BLAGOSKLONNY MV; NECKERS LM
      CYTOSTATIC AND CYTOTOXIC ACTIVITY OF SEX STEROIDS AGAINST HUMAN LEUKEMIA-CELL LINES

      Cancer letters
    70. MACHULAITENE YR; BLAGOSKLONNY MV
      THE INFLUENCE OF CONDITION MEDIA OF HUMAN BONE-MARROW FIBROBLASTS ON PROLIFERATION OF LEUKEMIC-CELL LINES

      Gematologia i transfuziologia
    71. BLAGOSKLONNY MV; NECKERS LM
      SENSITIVE AND SIMPLE BIOASSAY FOR HUMAN TUMOR-NECROSIS-FACTOR-ALPHA

      European cytokine network
    72. BLAGOSKLONNY MV; MACHULAITENE ER
      CONTROL OF HUMAN BONE-MARROW FIBROBLAST-LIKE CELL-PROLIFERATION

      Gematologia i transfuziologia


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/06/20 alle ore 02:25:59